All articles Are GLP-1 Medications Safe for Depression and Anxiety
Curtailing Copycats: On Thursday, the Food and Drug Administration proposed excluding the key ingredients in the popular weight-loss and obesity meds from its bulk compounding list, which could potentially limit the making of cheaper alternatives, a win for both Lilly and Novo.
This makes the peptide exceptionally valuable in in-vitro studies specifically focused on insulin secretion models, glycemic control pathways, lipid metabolism, and appetite-related neuroendocrine signaling
, 6, 750, 10.12688/f1000research.11120.1 118 TrinconiC
"I think the numbers continue to go up, just because patients are feeling more confident using these drugs, and the indications keep expanding," Egan said
While these agents are not yet formally approved for IIH, their potential dual benefit of weight loss and ICP reduction could substantially enhance the current management of IIH